Intensive versus conventional glucose control in critically Ill patients

New England Journal of Medicine

Volumn 360, Issue 13, 2009, Pages 1283-1297

  Finfer, Simon ^a,b   Bellomo, Rinaldo ^a   Blair, Deborah ^a   Su, Steve Yu Shuo ^a   Foster, Denise ^a   Dhingra, Vinay ^a   Cook, Deborah ^a   Dodek, Peter ^a   Henderson, William R ^a   Hébert, Paul C ^a   Heyland, Daren K ^a   McArthur, Colin ^a   McDonald, Ellen ^a   Mitchell, Imogen ^a   Myburgh, John A ^a   Nor ton, Robyn ^a   Potte, Julie ^a   Robinson, Bruce G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GEORGE INSTITUTE FOR INTERNATIONAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CAUSE OF DEATH; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; KIDNEY FAILURE; LENGTH OF STAY; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RISK ASSESSMENT; SEPTIC SHOCK; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CRITICAL ILLNESS; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED;

ADRENAL CORTEX HORMONES; BLOOD GLUCOSE; CRITICAL ILLNESS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; INTENSIVE CARE UNITS; KAPLAN-MEIERS ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED;

EID: 63249128249     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0810625     Document Type: Article

References (37)

1. Inzucchi SE. Management of hyper-glycemia in the hospital setting. N Engl J Med 2006;355:1903-11.
2. Capes SE, Hunt D, Malmberg K, Ger- stein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8.
3. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglyce- mia and prognosis of stroke in nondia- betic and diabetic patients: a systematic overview. Stroke 2001;32:2426-32.
4. Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg 2007;73:454-60.
5. Krinsley JS. Association between hy- perglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-8.
6. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction(DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-61.
7. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction(DIGAMI study): effects on mortality at 1 year. J Am Coll Car-diol 1995;26:57-65.
8. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
9. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39.
10. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
11. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pen- tastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
12. Van den Berghe G, Wouters P, Week-ers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-67.
13. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-61.
14. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300:933-44.
15. Langley J, Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab Res Rev 2007;23:184-92.
16. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13: Suppl 1:1-68.
17. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2008;31:Suppl 1:S12-S54.
18. Bellomo R, Egi M. Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR. Mayo Clin Proc 2005;80:1546-8.
19. Angus DC, Abraham E. Intensive insulin therapy in critical illness. Am J Res- pir Crit Care Med 2005;172:1358-9.
20. Shulman R, Finney SJ, O'Sullivan C, Glynne PA, Greene R. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Crit Care 2007;11:R75.
21. Chase JG, Shaw GM. Is there more to glycaemic control than meets the eye? Crit Care 2007;11:160.
22. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care 2006;15:370-7.
23. Mitchell I, Finfer S, Bellomo R, Hig- lett T. Management of blood glucose in the critically ill in Australia and New Zealand: a practice survey and inception cohort study. Intensive Care Med 2006;32: 867-74.
24. Mackenzie I, Ingle S, Zaidi S, Buczaski S. Tight glycaemic control: a survey of intensive care practice in large English hospitals. Intensive Care Med 2005;31:1136.
25. The NICE-SUGAR Study Investigators. The Normoglycemia in Intensiv Care Evaluation(NICE)(ISRCTN04968275) and Survival Using Glucose Algorithm Regulation(SUGAR) Study: development, design and conduct of an international multi-center, open label, randomized controlled trial of two target ranges for glyce-mic control in intensive care unit patients.Am J Respir Crit Care Med(online abstracts).(Accessed March 6, 2009, at http://ajrccm.atsjournals.org/ cgi/data/172/11/1358/DC1/1.)
26. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103-15.
27. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
28. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644- 55.
29. Vincent JL, de Mendonga A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multi-center, prospective study. Crit Care Med 1998;26:1793-800.
30. Finfer S, Heritier S. The NICE-SUGAR(Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) Study: statistical analysis plan. Crit Care Resusc 2009;11:46-57.
31. Su S. Numerical maximum log likelihood estimation for generalized lambda distributions. Comput Stat Data Anal 2007; 51:3983-98.
32. Idem. Fitting single and mixture of generalized lambda distributions to data via discretized and maximum likelihood methods: GLDEX in R. J Stat Software 2007;21:1-17.
33. The use of enteral nutrition vs. paren-teral nutrition: clinical practice guidelines. Kingston, ON, Canada: Critical Care Nutrition, 2007.(Accessed March 6, 2009, at http://www.criticalcarenutrition.com/docs/cpg/1.0-envspn-07.pdf.)
34. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55:3151-9.
35. Dunbar JC, O'Leary DS, Wang G, Wright-Richey J. Mechanisms mediating insulin-induced hypotension in rats: a role or nitric oxide and autonomic mediators. cta Diabetol 1996;33:263-8.insulin-induced hypotension in rats: a role or nitric oxide and autonomic mediators. cta Diabetol 1996;33:263-8.
36. erlein JA, Morgan DA, Phillips BG, aynes WG, Sivitz WI. Antecedent hypo-glycemia, catecholamine depletion, and ubsequent sympathetic neural responses. ndocrinology 2006;147:2781-8.
37. Krumholz HM, Lee TH. Redefining uality - implications of recent clinical rials. N Engl J Med 2008;358:2537-9.